Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The collaboration of six HTA bodies, including NICE, launched

31 Oct 2022

On October 12, 2022, the National Institute for Health and Care Excellence (NICE) announced the launch of an official collaboration with five other HTA bodies

  • Canadian Agency for Drugs and Technologies in Health (CADTH);
  • Australian Government Department of Health and Aged Care;
  • Healthcare Improvement Scotland;
  • Health Technology Wales (HTW);
  • All Wales Therapeutics & Toxicology Centre.

The arrangement will allow the partners to continue to remain independent of one another and work together on shared priorities to identify solutions to some of the common challenges they face. Five initial priority areas have been agreed upon:

  • COVID-19;
  • Futureproofing of HTA systems;
  • Collaborating with regulators;
  • Work-sharing and efficiency gains;
  • Digital and Artificial Intelligence.

Working groups aligned to the priority areas will meet quarterly to review progress and discuss activities in their area. An annual meeting of all partner organizations will be held to review all activities and realign the developing areas of collaboration where appropriate. The partnership could be expanded to include other HTA bodies in the future, subject to the agreement of existing members, with the signed agreement reviewed after two years.

See more information here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).